Teva Pharmaceuticals International GmbH v. Eli Lilly and Company > Summary
Court Case Number 1:17-cv-12087
Filing Date Oct 24, 2017
Termination Date Sep 27, 2018
Court Massachusetts District Court
Status Dismissed - Other
JudgesAllison D. Burroughs
Defendant
Plaintiff Attorneys
4Defendant Attorneys
7Eli Lilly and Company
Attorney Name: Adam R. Doherty
Prince Lobel Tye LLP
Eli Lilly and Company
Attorney Name: Danielle A. Duszczyszyn
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Emily R. Gabranski
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Andrea L. Martin
Burns & Levinson
Eli Lilly and Company
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
Eli Lilly and Company
Attorney Name: Daniel P. Tighe
Donnelly, Conroy & Gelhaar, LLP
Cause
28:2201 Declaratory Judgment
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09346881 | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | May 24, 2016 |
| 09340614 | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | May 17, 2016 |
| 09266951 | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | Feb 23, 2016 |
| 08597649 | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same | Dec 3, 2013 |
| 08586045 | Methods of using anti-CGRP antagonist antibodies | Nov 19, 2013 |
